PortViewPortView
BioDelivery Sciences International logo

BioDelivery Sciences International (BDSI) Stock Analysis

NASDAQHealthcareDrug Manufacturers - Specialty & Generic

$5.59-0.09%
1-year price historyRange $2.56 – $5.60
52-week range$5.59
$2.50$5.62

What BioDelivery Sciences International does

BioDelivery Sciences International, Inc. (BDSI) is a specialized pharmaceutical firm dedicated to the advancement and commercialization of therapeutic products designed for long-term health conditions, serving markets both within the United States and internationally. The company's product offerings leverage its proprietary BioErodible MucoAdhesive drug delivery system—a slender, dissolving polymer film intended for application to the inner cheek—in addition to other drug administration methodologies. Its portfolio includes several key products: BELBUCA, a buprenorphine buccal film, is utilized for the ongoing management of persistent pain. Symproic functions as a peripherally acting mu-opioid receptor antagonist, specifically addressing opioid-induced constipation in adult patients suffering from chronic non-cancer pain. This also covers individuals whose chronic pain is a result of prior cancer or its treatment, provided they do not require frequent increases in opioid dosage. ELYXYB, an oral solution containing celecoxib, provides treatment for adult migraines, irrespective of the presence of an aura. ONSOLIS, a soluble fentanyl film administered buccally, is intended for the management of sudden, severe "breakthrough" pain experienced by cancer patients. Founded in 1997, BioDelivery Sciences International, Inc. is headquartered in Raleigh, North Carolina. As of March 18, 2022, the company operates as a subsidiary of Collegium Pharmaceutical, Inc.

Key metrics

Market cap
$577.05M
P/E (TTM)
6.82
EPS (TTM)
$0.82
Beta
0.00
Dividend yield
0.00%
Revenue / share
$1.61
50-day avg
$4.96
200-day avg
$3.88
52-week high
$5.62
52-week low
$2.50
CEO
Herm Cukier

ETFs linked to BDSI

Broad-market and Healthcare sector ETFs an investor holding BioDelivery Sciences International is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how BDSI fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze BDSI in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for BioDelivery Sciences International?
BioDelivery Sciences International trades under the ticker BDSI on NASDAQ.
Which exchange is BDSI listed on?
BDSI is listed on NASDAQ.
What sector does BioDelivery Sciences International operate in?
BioDelivery Sciences International is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
How can PortView help analyze BDSI in a portfolio?
PortView shows BDSI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.